首页> 外文期刊>European review for medical and pharmacological sciences. >Hospitalization and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD): an Italian population-based study
【24h】

Hospitalization and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD): an Italian population-based study

机译:慢性阻塞性肺病急性加剧的住院和死亡率(COPD):一种基于意大利人群的研究

获取原文
           

摘要

OBJECTIVE: Patients with acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD) have a significant mortality and morbidity. Previous studies have identified a number of independent prognostic factors. However, information on hospital admission databases is limited and data regarding short-term prognosis of these patients in Italian hospitals are lacking. Thus, we performed an epidemiological study on hospital admission for COPD acute exacerbation in Italy. PATIENTS AND METHODS: Patients were identified using clinical Modification (ICD-9-CM) codes. Information was collected on baseline characteristics, vital status at discharge, duration of hospitalization, and up to five secondary discharge diagnoses. Comorbidity was evaluated using the Charlson comorbidity index (CCI). RESULTS: During the observation period (2013-2014), 170,684 patients with COPD acute exacerbation were hospitalized. Mean length of hospitalization (LOH) was 9.95±8.69 days and mean in-hospital mortality was 5.30%. These data correspond to the 4.1% of all hospitalizations and to the 2.8% of all the days of hospitalization in Italy during the study period. In-hospital mortality and LOH varied among different regions (from 3.13 to 7.59% and from 8.22 to 11.28 days respectively). Old age, male gender, low discharge volume, previous hospitalization for COPD exacerbation and CCI resulted as significantly associated with higher in-hospital mortality. CONCLUSIONS: Hospitalization for COPD exacerbation is extremely frequent even in contemporary Italian population. COPD exacerbation is clinically demanding with a not negligible short-term mortality rate and a mean LOH approaching 10 days. These latter findings were quite variable in different regions but should be further analyzed to set up appropriate health-care policies on COPD patients.
机译:目的:慢性阻塞性肺病(COPD)急性加剧患者具有显着的死亡率和发病率。以前的研究已经确定了许多独立的预后因素。然而,有关医院入学数据库的信息是有限的,并且缺乏关于这些患者的短期预后的数据。因此,我们对意大利COPD急性加剧的医院入院进行了流行病学研究。患者和方法:使用临床改性(ICD-9-CM)代码鉴定患者。信息被收集在基线特征,放电持续时间,住院时间和最多五次二级放电诊断。使用Charlson合并症指数(CCI)评价合并症。结果:在观察期(2013-2014)期间,170,684名具有住院的COPD急性加剧患者。住院治疗的平均长度(LOH)为9.95±8.69天,平均医院死亡率为5.30%。这些数据对应于所有住院的4.1%以及在研究期间意大利入院时间的2.​​8%。在医院死亡率和LOH在不同地区各种各样的(分别为3.13至7.59%,分别为8.22至11.28天)。晚年,男性性别,低放电体积,以前的COPD Exacterbation和CCI住院治疗导致高于医院内死亡率显着相关。结论:即使在当代意大利人口中,COPD Exacterbation的住院也极其频繁。 COPD Exacterbation在临床上要求临床要求,不可忽略的短期死亡率和平均LOH接近10天。后一种结果在不同地区非常变化,但应进一步分析,以在COPD患者中建立适当的保健政策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号